KeyBanc upgraded Adobe (ADBE) to Sector Weight from Underweight noting that shares are fairly valued and there is probably ...

Investing.com -- KeyBanc Capital Markets upgraded Celanese (NYSE: CE) Corp to “Overweight” from “Sector Weight,” citing expectations of a modest earnings recovery and improved margins in the company’s ...

Eaton ( NYSE: ETN) late Tuesday was upgraded to Overweight from a previous investment rating of Sector Weight by analysts at ...

Investing.com -- KeyBanc Capital Markets upgraded Eaton (NYSE: ETN) Corp to “Overweight” with a $340 price target on ...

Investing.com -- KeyBanc Capital Markets upgraded Eaton (NYSE:ETN) Corp to “Overweight” with a $340 price target on company’s strong growth prospects in electrification and aerospace sector ...

Lin, Executive Vice President and Chief Financial Officer, will participate in the Virtual KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, 2025, which includes a presentation ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...

MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced that management will participate in the KeyBanc Capital Markets Healthcare Forum to be ...

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions ...

TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced that management will participate in the KeyBanc Capital Markets Healthcare Forum to be held virtually on March 18-19 ...

TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced that management will participate in the KeyBanc Capital Markets Healthcare Forum to be held virtually on March 18-19, ...

Azenta provides a full suite of reliable cold-chai sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the ...